Myeloma and leukaemia trials.
作者信息
Peto R
出版信息
Proc R Soc Med. 1972 Mar;65(3):244-5. doi: 10.1177/003591577206500307.
Abstract
摘要
相似文献
1
Myeloma and leukaemia trials.
Proc R Soc Med. 1972 Mar;65(3):244-5. doi: 10.1177/003591577206500307.
2
Monitoring myelomatosis.监测骨髓瘤
Arch Intern Med. 1975 Jan;135(1):125-30.
3
Proposed guidelines for protocol studies. I. Introduction. II. Plasma cell myeloma. 3. Chronic lymphocytic leukemia. IV. Chronic granulocytic leukemia.
Cancer Chemother Rep 3. 1973 Jan;4(1):141-73.
4
Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.首例骨髓瘤试验报告。I. 对具有预后重要性的呈现特征的分析。
Br J Haematol. 1973 Jan;24(1):123-39.
5
Myeloma and related disorders.骨髓瘤及相关病症。
Rev Invest Clin. 1994 Apr;Suppl:46-51.
6
Urea, albumin, and response rates.尿素、白蛋白及反应率。
Br Med J. 1971 May 8;2(5757):324. doi: 10.1136/bmj.2.5757.324.
7
Is the newly proposed prognostic system for multiple myeloma useful?
Br J Haematol. 1990 May;75(1):140-1. doi: 10.1111/j.1365-2141.1990.tb02634.x.
8
9
Clinical trials referral resource. Clinical trials with arsenic trioxide.
Oncology (Williston Park). 2000 Feb;14(2):206, 211, 215-6 passim.
10
International staging system for multiple myeloma.多发性骨髓瘤国际分期系统
J Clin Oncol. 2005 May 20;23(15):3412-20. doi: 10.1200/JCO.2005.04.242. Epub 2005 Apr 4.
Zotero 插件